Drug Discovery Europe 2026

Drug Discovery Europe is where artificial intelligence, advanced biology and translational science converge to transform the earliest stages of drug discovery. Over 1,000 senior scientists, R&D leaders and technology innovators from pharma, biotech and AI-driven platforms. Two days in Berlin built around the questions the field is actually asking in 2026.

Dr. Martin Kriebel (Senior Principal Scientist in the Next Generation Cellular and Organotypic Assays division) will give a presentation titled: “Closing the gap: Patient-derived microtumors (PDMs) in precision oncology and preclinical drug development”.

You can find more information here: https://oxfordglobal.com/discovery-development/events/discovery-development-europe/drug-discovery-europe